Somar
Grupo Somar is a Mexico City-based private pharmaceutical company founded in 2011, operating with 501–1,000 employees and serving institutional and distributor buyers through a dedicated B2B portal.
- Company typePrivate
- Founded2011
- HeadquartersMexico City, Mexico
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Somar does
Grupo Somar (legally Grupo Somar – Grupo Farmacéutico) is a privately held pharmaceutical company headquartered in Mexico City, founded in 2011 and operating with an employee base in the 501–1,000 range. Its corporate identity, channels, and business activity are anchored in the Mexican pharmaceutical sector, serving what appears to be an institutional and distributor customer base. The only public-facing product offering documented in available sources is a B2B portal (somar.portalhib2b.com), which the company uses to provide ordering or partner access for its pharmaceutical portfolio to business customers.
The company operates almost entirely off a single online touchpoint: its corporate website at gruposomar.com, which is currently in maintenance mode and routes visitors to its LinkedIn page and the B2B portal. Distribution is structured through a wholesale/distributor channel targeting enterprise buyers, with a linked whistleblower hotline (letica.mx/GrupoSomar) signaling standard corporate compliance infrastructure. No pricing, public product catalog, certifications, app presence, API, or integration ecosystem is publicly disclosed.
The business model is B2B pharmaceutical distribution, monetized through sales of pharmaceutical products to institutional buyers via the dedicated portal. Capital structure is opaque: a single $500,000 funding event is recorded in 2017 from investor Envelp, which is inconsistent with the company's stated headcount and may reflect limited public disclosure rather than true capital intensity. Leadership consists of CEO Daniel Del Conde and CFO Guillermo Perea Lopez, with no additional management team disclosed.
Somar firmographics
Firmographics- Name
- Somar
- Legal name
- Grupo Somar
- Website
- https://gruposomar.com
- Company type
- Private
- Founded year
- 2011
- Headcount range
- 501–1,000 employees
- Short description
- Grupo Somar is a Mexico City-based private pharmaceutical company founded in 2011, operating with 501–1,000 employees and serving institutional and distributor buyers through a dedicated B2B portal.
- Ownership category
- akta.pro rank
Where Somar is headquartered
LocationHeadquarters
- HQ city
- Mexico City
- HQ country
- Mexico
- HQ region
- Latin America
Markets served
Somar business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
Somar product offering
Product offeringCore offering
Somar is a Mexican pharmaceutical group (Grupo Somar – Grupo Farmacéutico) that manufactures and distributes pharmaceutical products. The only publicly named commercial offering is a B2B portal (somar.portalhib2b.com) that gives business buyers — distributors, wholesalers and institutional partners — access to its pharmaceutical portfolio. The corporate website is currently under maintenance and does not list the full product catalog.
Product overview
Somar (Grupo Somar – Grupo Farmacéutico) is a pharmaceutical group. The public website is currently under maintenance ("Sitio en mantenimiento") and does not describe the company's full product portfolio. The only named offering referenced on the page is a B2B portal (somar.portalhib2b.com), intended for business customers. No additional product modules, brands, or sub-products are documented in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Grupo Somar B2B Portal Dedicated B2B portal accessible at somar.portalhib2b.com that gives business customers — pharmaceutical distributors, wholesalers and institutional buyers — access to Grupo Somar's pharmaceutical products. The portal's specific transaction functionality is not described on the corporate site.
Companies that use Somar
Customer profileIdeal customer profiles1 record
Somar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Somar partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
Somar competitors and assessment
Company assessmentDirect peers
- Genomma Lab: One of Mexico's largest domestic pharmaceutical companies, focused on OTC and branded generics. Highly comparable to Somar as a Mexico-headquartered pharma group serving the same market and channels.
- Productos Maver: Mexican pharmaceutical company offering generics and branded products across multiple therapeutic areas. Comparable to Somar as a domestic pharma group competing in similar retail and institutional channels.
- Chinoin: Historic Mexican pharmaceutical manufacturer (part of P&G's prior pharma portfolio, now Aspen Pharmacare). Comparable to Somar as a domestic pharma group with a long Mexican operating history.
- Laboratorios Liomont: Long-established Mexican pharmaceutical manufacturer with a broad branded-generic and OTC portfolio. Comparable to Somar as a domestic Mexican pharma group of similar size and market positioning.
- PiSA Farmacéutica: One of Mexico's leading pharma manufacturers with hospital, retail, and institutional distribution. Comparable to Somar's institutional/B2B distribution orientation within the domestic Mexican market.
- Laboratorios Sophia: Mexican pharmaceutical group with a strong specialty and institutional presence. Comparable to Somar as a Mexico-based pharma company with similar channel mix.
Regional players
- Asofarma: Latin American-focused pharmaceutical company with significant presence across Mexico and other LATAM markets. Comparable as a regional pharma player with overlapping therapeutic and channel exposure.
Broad incumbents
- Novartis Mexico: Multinational pharmaceutical company with established Mexico operations across innovative medicines and generics (Sandoz). Comparable as a broader incumbent competing in the same institutional and retail channels.
- Bayer Mexico: Global life sciences company with a substantial Mexico pharmaceutical and consumer health presence. Comparable as a broader incumbent operating in overlapping OTC and prescription categories in Mexico.
- Sanofi Mexico: Multinational pharmaceutical company with a major Mexico subsidiary spanning prescription, OTC, and vaccines. Comparable as a broader incumbent competing for the same institutional and retail channels in Mexico.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights5 records
Customer concentration
Somar social profiles
Digital presenceSomar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Somar leadership team
Management profileNumber of profiles
Profiles2 records
Somar funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Somar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Somar
What does Somar do?
Somar is a Mexican pharmaceutical group (Grupo Somar – Grupo Farmacéutico) that manufactures and distributes pharmaceutical products. The only publicly named commercial offering is a B2B portal (somar.portalhib2b.com) that gives business buyers — distributors, wholesalers and institutional partners — access to its pharmaceutical portfolio. The corporate website is currently under maintenance and does not list the full product catalog.
Is Somar a public or private company?
Somar is a private company. It is classified as unknown.
When was Somar founded?
Somar was founded in 2011. It employs 501 to 1,000 people.
Where is Somar based?
Somar is headquartered in Mexico City, Mexico, in the Latin America region.
Who are Somar's main competitors?
Direct peers on record are Genomma Lab, Productos Maver, Chinoin, Laboratorios Liomont, PiSA Farmacéutica and Laboratorios Sophia. Asofarma is listed as a regional player. Broad incumbents are Novartis Mexico, Bayer Mexico and Sanofi Mexico.
Does Somar have an API?
No public API is recorded for Somar.